Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2017 |
| Author/s |
author: Silvia C. Formenti Narek Shaverdian |
| Publication date | May 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |